DIA's 9th Conference on European Electronic Document Management
Drug Information Association (DIA) is conducting an event called 9th Conference on European Electronic Document Management which will be held from 03rd December 2008 in Barcelona, Spain.
Drug Information Association (DIA) is conducting an event called 9th Conference on European Electronic Document Management which will be held from 03rd December 2008 in Barcelona, Spain.
Event Overview:
During the past decades we dreamed, anticipated, waited for a future time when technology would shape a new landscape for EDM. Many of the components have been around for quite a long time. Others are just emerging. But now, for the first time, that future has come to being. EDM in many different shapes, spanning from home-grown systems to hosted repositories, has become the established method for managing official documentation. Registration dossiers are built electronically even for paper submissions and safety information is exchanged in electronic formats. Is this the end of the story? Certainly not but this much is certain: the future we dreamed of then, is now.
Target Audience:
• Document and eRecords Managers
• Standards Implementation Specialists and Associates
• Quality Assurance and Compliance Professionals
• Medical Writers
• IT and Support Personnel
• Contract Researchers and Service Support Providers
• Regulatory Affairs / Operations Professionals
• Academic Researchers
• Regulatory Authority Representatives
• Validation Professionals
• Pharmacovigilance Professionals
• Knowledge / IP Professionals
Can we request you to update the calendar of events on your website to include the details of this event? The details of the event are given below as well as attached. Please let me know if you need any further information.
Event Name
9th Conference on European Electronic Document Management
Event Date
Dec 03 2008 - Dec 05 2008
Event Location
Hilton Barcelona, Barcelona, Spain.
Event Description
During the past decades we dreamed, anticipated, waited for a future time when technology would shape a new landscape for EDM. Many of the components have been around for quite a long time. Others are just emerging. But now, for the first time, that future has come to being. EDM in many different shapes, spanning from home-grown systems to hosted repositories, has become the established method for managing official documentation. Registration dossiers are built electronically even for paper submissions and safety information is exchanged in electronic formats. Is this the end of the story? Certainly not but this much is certain: the future we dreamed of then, is now.
Event Website
http://www.diahome.org/DIAHOME/Education/FindEducationalOffering.aspx?productID=17015&eventType=Meeting
Contact Person
Senior Manager of Marketing
Contact E-Mail ID
talana.bertschi@diaeurope.org
Contact Phone
+41 61 225 51 51
Contact Fax
+41 61 225 51 52
Sponsoring Company Name
Drug Information Association
Company Website
http://www.diahome.org
Company Address
Drug Information Association, European Branch Office, Basel, Switzerland.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Beyond the Molecule: How Human-Centered Design Unlocks AI's Promise in Pharma
June 23rd 2025How human-centered AI that is focused on customer, user, and employee experience can drive real transformation in clinical trials and beyond by aligning intelligent technologies with the people who use them.
2025 DIA Annual Meeting: Why AI and Automation Are Set to Become the New Normal in Clinical Research
June 20th 2025Peter Ronco, CEO, Emmes, shares his long-term vision for artificial intelligence in clinical research, from making automation routine to improving drug discovery, transforming regulatory oversight, reducing animal testing, and promoting ethical, equitable data use worldwide.
